Ajooni Biotech Intrinsic Value
Ajooni Biotech (AJOONI) median intrinsic value is ₹8.40 from 8 valuation models (range ₹1–₹12), vs current price ₹4.20 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read AJOONI dividend history for the complete payout history and dividend yield track record.
AJOONI Valuation Methods Summary — DCF, Graham Number & P/E
Ajooni Biotech intrinsic value across 8 models vs current price ₹4.20 — upside/downside and value range per method. Analyse AJOONI institutional holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹3.00 | ₹2.40 - ₹3.60 | -28.6% | EPS: ₹0.25, Sector P/E: 12x |
| Book Value Method | asset | ₹10.50 | ₹9.45 - ₹11.55 | +150.0% | Book Value/Share: ₹26.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹8.40 | ₹7.56 - ₹9.24 | +100.0% | Revenue/Share: ₹52.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹8.40 | ₹7.56 - ₹9.24 | +100.0% | EBITDA: ₹6.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹10.50 | ₹8.40 - ₹12.60 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.26 | ₹1.13 - ₹1.39 | -70.0% | EPS Growth: 4.5%, Fair P/E: 3.6x |
| Growth Adjusted P/E | growth | ₹2.15 | ₹1.94 - ₹2.37 | -48.8% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹12.09 | ₹10.88 - ₹13.30 | +187.9% | EPS: ₹0.25, BVPS: ₹26.00 |
AJOONI Intrinsic Value vs Market Price — All Valuation Models
Ajooni Biotech fair value range ₹1–₹12 vs current market price ₹4.20 across 8 valuation models. For current market price and key ratios, visit AJOONI share price.
AJOONI Intrinsic Value Analysis — Undervalued or Overvalued?
Ajooni Biotech median intrinsic value ₹8.40, current price ₹4.20 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of AJOONI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Ajooni Biotech (AJOONI) is ₹8.40 (median value). With the current market price of ₹4.20, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.26 to ₹12.09, indicating ₹1.26 - ₹12.09.
Is AJOONI undervalued or overvalued?
Based on our multi-method analysis, Ajooni Biotech (AJOONI) appears to be trading below calculated value by approximately 100.0%.
AJOONI Financial Health — Key Ratios vs Industry Benchmarks
Ajooni Biotech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 37.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.52x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
AJOONI Cash Flow Quality — Operating & Free Cash Flow
Ajooni Biotech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-18 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹23 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |